InvestorsHub Logo
Followers 12
Posts 1019
Boards Moderated 0
Alias Born 03/24/2013

Re: None

Wednesday, 06/18/2014 11:36:40 AM

Wednesday, June 18, 2014 11:36:40 AM

Post# of 427504
I realize what some you guys were saying about FDA being corrupt:

Just came across the words of Adam Feuerstein on 06/19/2013 (before the AdCom):


"....I tend to believe FDA is convening this panel because it's wary of expanding Vascepa's use without definitive proof that fish oil reduces the risk of heart attack, strokes and other cardiovascular events.... I expect many of the experts, most notably the cardiologists, sitting on the Oct. 16 FDA panel will want to see Reduce-It trial data before agreeing to expand Vascepa's use. Too many large studies of fish-oil have failed recently to show any significant cardiovascular benefit for patients...."

Did AF managed to interview some panel members or the FDA reviewer???


link
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News